HomeCompareISO vs BTI

ISO vs BTI: Dividend Comparison 2026

ISO yields 262.61% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ISO wins by $630.55M in total portfolio value
10 years
ISO
ISO
● Live price
262.61%
Share price
$0.76
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$630.59M
Annual income
$360,525,279.87
Full ISO calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — ISO vs BTI

📍 ISO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodISOBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ISO + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ISO pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ISO
Annual income on $10K today (after 15% tax)
$22,321.43/yr
After 10yr DRIP, annual income (after tax)
$306,446,487.89/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, ISO beats the other by $306,444,119.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ISO + BTI for your $10,000?

ISO: 50%BTI: 50%
100% BTI50/50100% ISO
Portfolio after 10yr
$315.31M
Annual income
$180,264,033.26/yr
Blended yield
57.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

ISO
Analyst Ratings
2
Buy
2
Hold
Consensus: Buy
Altman Z
-5.0
Piotroski
1/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ISO buys
0
BTI buys
0
No recent congressional trades found for ISO or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricISOBTI
Forward yield262.61%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$630.59M$37.7K
Annual income after 10y$360,525,279.87$2,786.64
Total dividends collected$602.26M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: ISO vs BTI ($10,000, DRIP)

YearISO PortfolioISO Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$36,961$26,260.50$11,299$598.92+$25.7KISO
2$130,258$90,710.42$12,794$703.91+$117.5KISO
3$438,149$298,772.37$14,518$829.07+$423.6KISO
4$1,408,052$939,232.60$16,513$978.64+$1.39MISO
5$4,327,508$2,820,892.40$18,827$1,157.84+$4.31MISO
6$12,732,989$8,102,555.47$21,518$1,373.12+$12.71MISO
7$35,905,096$22,280,798.19$24,657$1,632.46+$35.88MISO
8$97,136,649$58,718,196.61$28,329$1,945.74+$97.11MISO
9$252,398,437$148,462,222.43$32,637$2,325.33+$252.37MISO
10$630,591,608$360,525,279.87$37,708$2,786.64+$630.55MISO

ISO vs BTI: Complete Analysis 2026

ISOStock

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.

Full ISO Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this ISO vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ISO vs SCHDISO vs JEPIISO vs OISO vs KOISO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.